Cleared Traditional

K844734 - ALCIDE REN NEW-D

K844734 is an FDA 510(k) clearance for ALCIDE REN NEW-D, manufactured by Alcide Corp.. The device is a Class 2 Gastroenterology & Urology device with product code FKQ cleared through the Traditional 510(k) pathway after a 164-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1985
Decision
164d
Days
Class 2
Risk

K844734 is an FDA 510(k) clearance for the ALCIDE REN NEW-D. Classified as System, Dialysate Delivery, Central Multiple Patient (product code FKQ), Class II - Special Controls.

Submitted by Alcide Corp. (Westport, US). The FDA issued a Cleared decision on May 17, 1985 after a review of 164 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5820 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K844734

510(k) Number K844734 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 04, 1984
Decision Date May 17, 1985
Days to Decision 164 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d slower than avg
Panel avg: 131d · This submission: 164d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FKQ Device Classification - Class 2, Special Controls

Product Code FKQ System, Dialysate Delivery, Central Multiple Patient
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5820
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FKQ System, Dialysate Delivery, Central Multiple Patient

All 60
Devices cleared under the same product code (FKQ) and FDA review panel - the closest regulatory comparables to K844734.
HEMODIALYSIS CONCENTRATE
K854391 · Dana Laboratories · Jan 1986
RECOMMENDED ALTERNATIVE DIALYZER DISINFECTANT
K852749 · Mesa Medical, Inc. · Sep 1985
NATURALYTE BICARBONATE CONCENTRATE-DRY PACK
K852310 · Erika, Inc. · Jul 1985
MEDICORP DEHYDRACON A DEHYDRATED DIALYSATE CONCENT
K844850 · Medicorp, Inc. · Apr 1985
FRESENIUS A2008 HEMODIALYSIS MACHINE EXPANSION MOD
K844750 · Seratronics, Inc. · Feb 1985
FRESENIUS HAEMODIALYSIS
K844641 · Seratronics, Inc. · Feb 1985